Publicaciones en colaboración con investigadores/as de Radboud University Nijmegen Medical Centre (16)

2023

  1. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  2. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes

    The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106

  3. Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi

    Molecular Therapy Nucleic Acids, Vol. 34

2022

  1. SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin

    Frontiers in Pharmacology, Vol. 13

  2. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models

    Journal of Hepatology, Vol. 77, Núm. 1, pp. 177-190

2020

  1. Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets

    Liver International, Vol. 40, Núm. 7, pp. 1670-1685

  2. Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer

    European Journal of Cancer, Vol. 135, pp. 173-182

  3. Sarcoma treatment in the era of molecular medicine

    EMBO Molecular Medicine, Vol. 12, Núm. 11

2019

  1. The clinical application of cancer immunotherapy based on naturally circulating dendritic cells

    Journal for ImmunoTherapy of Cancer, Vol. 7, Núm. 1

2016

  1. Anti-CD137 monoclonal antibodies and adoptive T cell therapy: a perfect marriage?

    Cancer Immunology, Immunotherapy

2015

  1. Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, Núm. 24, pp. 7551-7556

2014

  1. Awareness and understanding of cancer immunotherapy in Europe

    Human Vaccines and Immunotherapeutics, Vol. 10, Núm. 7, pp. 1828-1835

  2. Comparing algorithms for automated vessel segmentation in computed tomography scans of the lung: The VESSEL12 study

    Medical Image Analysis, Vol. 18, Núm. 7, pp. 1217-1232

  3. Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: Two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts

    PLoS ONE, Vol. 9, Núm. 12

  4. The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: A meta-analysis in patients with cancer

    Pharmacogenomics Journal, Vol. 14, Núm. 2, pp. 115-119

2012

  1. Smoking history and lung carcinoma: KRAS mutation is an early hit in lung adenocarcinoma development

    Lung Cancer, Vol. 75, Núm. 2, pp. 156-160